Beyond the use of apoC1 level as a new marker of diabetes severity, the restoration of apoC1 functionality might help to counteract the deleterious effects of increased CETP activity on plasma lipoprotein profile in this population at high cardiovascular risk. This evidence concerns the gene APOC1 and diabetes mellitus.